Skip to search formSkip to main contentSkip to account menu

Rocuronium

Known as: 1-(17-(acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Background and objectives: This prospective, double‐blind, randomized, placebo‐controlled study was designed to determine the… 
2004
2004
Background : Cerebrovascular stability and rapid anesthetic emergence are desirable features of a neuroanesthetic regimen. In… 
Highly Cited
2003
Highly Cited
2003
Background and objective: Rocuronium and, to a lesser extent, vecuronium can induce burning sensations associated with withdrawal… 
2003
2003
We evaluated the pretreatment of small-dose of ketamine or normal saline in the reduction of withdrawal movements induced by… 
Highly Cited
2002
Highly Cited
2002
Rapid-sequence induction with cricoid pressure is a standard procedure for inducing anesthesia in patients with a potentially… 
2002
2002
BACKGROUND AND OBJECTIVE The aim was to compare the effects of two different priming doses and priming intervals with the… 
1998
1998
We compared the dose–response relationships of cisatracurium, mivacurium, atracurium, vecuronium and rocuronium and examined the… 
1997
1997
PurposeThe aim of this study was to assess the effect of rocuronium pretreatment at 3 and 1.5 min before succinylcholine… 
1994
1994
The aim of this study was to compare, in 30 patients, the pharmacodynamics of equipotent intubating doses of rocuronium and…